Fat metabolism during exercise in patients with McArdle disease, Neurology, vol.72, pp.718-724, 2009. ,
Effect of changes in fat availability on exercise capacity in McArdle disease, Arch Neurol, vol.66, pp.762-766, 2009. ,
Metabolic profiles of exercise in patients with McArdle disease or mitochondrial myopathy, Proc Natl Acad Sci, vol.114, pp.8402-8407, 2017. ,
Tricarboxylic acid cycle intermediates during incremental exercise in healthy subjects and in patients with McArdle's disease ,
, Clin Sci, vol.88, pp.687-693, 1995.
Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride, J Clin Invest, vol.110, pp.259-269, 2002. ,
Anaplerotic diet therapy in inherited metabolic disease: therapeutic potential, J Inherit Metab Dis, vol.29, pp.332-340, 2006. ,
Carnitine palmitoyltransferase II deficiency: successful anaplerotic diet therapy, Neurology, vol.71, pp.260-264, 2008. ,
Anaplerotic treatment of longchain fat oxidation disorders with triheptanoin: review of 15 years experience, Mol Genet Metab, vol.116, pp.260-268, 2015. ,
Triheptanoin: a rescue therapy for cardiogenic shock in carnitineacylcarnitine translocase deficiency, JIMD Rep, vol.39, pp.19-23, 2017. ,
Triheptanoin treatment in patients with pediatric cardiomyopathy associated with long chain-fatty acid oxidation disorders ,
, Mol Genet Metab, vol.119, pp.223-231, 2016.
Pyruvate carboxylase deficiency: clinical and biochemical response to anaplerotic diet therapy, Mol Genet Metab, vol.84, pp.305-312, 2005. ,
Triheptanoin for the treatment of brain energy deficit: a 14-year experience, J Neurosci Res, vol.95, pp.2236-2243, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01840222
Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats. II. Effects on lipolysis, glucose production, and liver acyl-CoA profile, Am J Physiol -Endocrinol Metab, vol.298, pp.362-371, 2010. ,
Interrelations between C4 ketogenesis, C5 ketogenesis, and anaplerosis in the perfused rat liver, J Biol Chem, vol.284, pp.27799-27807, 2009. ,
Heptanoate as a neural fuel: energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brain, J Cereb Blood Flow Metab, vol.33, pp.175-182, 2013. ,
Psychophysical bases of perceived exertion, Med Sci Sports Exerc, vol.14, pp.377-381, 1982. ,
Organic acids in man: analytical chemistry, biochemistry and diagnosis of the organic Acidurias ,
, , 1982.
Quantitative plasma acylcarnitine analysis using electrospray tandem mass spectrometry for the diagnosis of organic acidaemias and fatty acid oxidation defects, J Inherit Metab Dis, vol.22, pp.302-306, 1999. ,
Aerobic conditioning: an effective therapy in McArdle's disease ,
, Ann Neurol, vol.59, pp.922-928, 2006.
The effect of oral sucrose on exercise tolerance in patients with McArdle's disease, N Engl J Med, vol.349, pp.2503-2509, 2003. ,
Adult polyglucosan body disease (APBD): anaplerotic diet therapy (Triheptanoin) and demonstration of defective methylation pathways, Mol Genet Metab, vol.101, pp.246-252, 2010. ,
UX007 for the treatment of long chain-fatty acid oxidation disorders: safety and efficacy in children and adults following 24 weeks of treatment, Mol Genet Metab, vol.120, pp.370-377, 2017. ,
Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment-a retrospective chart review, Mol Genet Metab, vol.116, pp.53-60, 2015. ,
Dietary anaplerotic therapy improves peripheral tissue energy metabolism in patients with Huntington's disease, Eur J Hum Genet, vol.18, pp.1057-1060, 2010. ,
Anaplerotic molecules: current and future, J Inherit Metab Dis, vol.29, pp.327-331, 2006. ,
A pilot study of addon oral triheptanoin treatment for children with medically refractory epilepsy, Eur J Paediatr Neurol, vol.22, pp.1074-1080, 2018. ,
Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency, J Neurol Neurosurg Psychiatry, vol.87, pp.550-553, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01325371
Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial, J Inherit Metab Dis, vol.40, pp.831-843, 2017. ,
A doubleblind, placebo-controlled trial of triheptanoin in adult polyglucosan body disease and open-label, long-term outcome, J Inherit Metab Dis, vol.41, pp.877-883, 2018. ,
A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood, Orphanet J Rare Dis, vol.12, p.160, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-01612741
Myocardial energy shortage and unmet anaplerotic needs in the fasted long-chain acyl-CoA dehydrogenase knockout mouse, Cardiovasc Res, vol.100, pp.441-449, 2013. ,
Impaired oxidative metabolism increases adenine nucleotide breakdown in McArdle's disease, J Appl Physiol, vol.69, pp.1231-1235, 1990. ,
Favorable responses to acute and chronic exercise in McArdle patients, Clin J Sport Med, vol.17, pp.297-303, 2007. ,
Feasibility of resistance training in adult McArdle patients: clinical outcomes and muscle strength and mass benefits, Front Aging Neurosci, vol.6, p.334, 2014. ,
No spontaneous second wind in muscle phosphofructokinase deficiency, Neurology, vol.62, pp.82-86, 2004. ,
, The Authors. Annals of Clinical and Translational Neurology, 2019.